DNA X, Inc.
SONMdata completeness 75%8 fiscal years on fileDNA X, Inc. earns about -297% on invested capital, and has bought back 92% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $54.6M1 | $69.8M2 | $93.6M3 | $50.9M3 | — |
| Net income | −$38.6M4 | −$14.1M5 | −$90,0006 | −$33.6M7 | −$20.7M7 |
| Operating cash flow | −$38.5M8 | −$12.4M9 | −$4.05M10 | −$8.49M11 | −$23.5M11 |
| Capital expenditure | $46,00012 | $8,00013 | $36,00014 | $214,00015 | — |
| Free cash flow (derived) | −$38.5M8 | −$12.4M9 | −$4.09M10 | −$8.7M11 | — |
| Total debt | $214,00016 | $147,00017 | — | — | $10.1M18 |
| Cash & equivalents | $11.2M19 | $13.2M20 | $9.4M21 | $5.34M22 | $1.3M22 |
| Diluted shares | 9.5M | 28.9M | 4.3M | 262,118 | 722,689 |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$110.08 of net worth that earned you −$285.84 last year, against $140.17 of debt.
It earned an average -297% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 92% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 4634% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-001720 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-001720 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016659 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-001720 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016659 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-001720 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016659 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (LongTermDebtCurrent)
- 10-K · period ending 2025-12-31 · accession 0001493152-26-016659 (LongTermDebtCurrent)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-008199 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-011530 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-001720 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016659 (CashAndCashEquivalentsAtCarryingValue)